USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/7185
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBotnaru, Victor
dc.contributor.authorMunteanu, Oxana
dc.contributor.authorRusu, Doina
dc.contributor.authorOnea, Leonid
dc.date.accessioned2019-11-28T14:08:36Z
dc.date.available2019-11-28T14:08:36Z
dc.date.issued2014
dc.identifier.citationBOTNARU, Victor, MUNTEANU, Oxana, RUSU, Doina, ONEA, Leonid. Pneumonita interstiţială indusă de terapia antivirală cu interferon. In: Sănătate Publică, Economie şi Management în Medicină. 2014, nr. 5(56), pp. 76-79. ISSN 1729-8687.en_US
dc.identifier.issn1729-8687
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/7185
dc.identifier.urihttp://revistaspemm.md/wp-content/uploads/2019/05/cm5_56_2014.pdf
dc.descriptionDepartamentul Medicină Internă, Disciplina Pneumologie/Alergologie, USMF Nicolae Testemiţanu, Centrul de Diagnostic German, or. Chişinău, Conferinţa Naţională de Gastroenterologie și Hepatologie cu participare internaţională 20 iunie 2014 Chişinău, Republica Moldovaen_US
dc.description.abstractPulmonary toxicity is an exceptional but unanticipated complication of interferon (IFN) treatment. Interstitial pneumonitis (IP) can occur at any stage of IFN therapy. Prompt discontinuation of medication is the cornerstone. The severity of pulmonary injury may be associated with the rapid development of IP indicating the necessity of methylprednisolone pulse therapy, followed by low dose prednisolone therapy for a short term.en_US
dc.description.abstractРазвитие лекарственных поражений легких является исключительным и непредвиденным осложнением лечения интерфероном. Интерстициальный пневмонит (ИП) может развиться на любом этапе терапии. Отмена препарата является ключевым фактором успеха. Тяжесть повреждения легких может быть связана с быстрым развитием ИП, указывающим на необходимость пульс-терапии метилпреднизолоном с последуюшим применением небольших доз преднизолона в течение короткого срока.
dc.language.isoroen_US
dc.publisherAsociația Obștească ”Economie, Management și Psihologie în Medicină” din Republica Moldovaen_US
dc.subjecthepatitisen_US
dc.subjectinterferonen_US
dc.subjectinterstitial pneumonitisen_US
dc.subjectcorticosteroid therapyen_US
dc.subject.meshLung Diseases, Interstitial--diagnosisen_US
dc.subject.meshLung Diseases, Interstitial--pathologyen_US
dc.subject.meshIdiopathic Interstitial Pneumonias --diagnosisen_US
dc.subject.meshIdiopathic Interstitial Pneumonias--etiologyen_US
dc.subject.meshInterferons--adverse effectsen_US
dc.subject.meshAdrenal Cortex Hormones--therapeutic useen_US
dc.titlePneumonita interstiţială indusă de terapia antivirală cu interferonen_US
dc.title.alternativeInterstitial pneumonitis caused by antiviral therapy with interferonen_US
dc.title.alternativeИнтерстициальный пневмонит, вызванный противовирусной терапией интерферономen_US
dc.typeArticleen_US
Appears in Collections:Sănătate Publică, Economie şi Management în Medicină Nr. 5 (56) / 2014

Files in This Item:
File Description SizeFormat 
PNEUMONITA_INTERSTITIALA.pdf281.76 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback